Choroidal Neovascularization (Type 1) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Choroidal Neovascularization (Type 1)
Choroidal Neovascularization Type 1 (CNV Type 1) is a serious eye condition where abnormal blood vessels grow beneath the retina, potentially leading to vision loss. Managing CNV Type 1 often involves costly treatments, but affording your medications doesn't have to be a burden. TheDrugClub offers significant savings on prescription drugs, helping you maintain your vision and financial well-being.
What is Choroidal Neovascularization Type 1?
Choroidal Neovascularization Type 1 (CNV Type 1) is an ocular condition characterized by the growth of new, abnormal blood vessels from the choroid (the vascular layer beneath the retina) into the subretinal pigment epithelium (RPE) space. These fragile new vessels can leak fluid and blood, causing retinal swelling, scarring, and ultimately, severe vision loss if left untreated. CNV Type 1 is a common complication of age-related macular degeneration (AMD), particularly the "wet" form, but it can also occur due to other conditions like high myopia, ocular histoplasmosis, or angioid streaks. Early detection through regular eye exams, especially if you experience blurred vision, distorted lines, or a central blind spot, is crucial for preserving sight.
Common Treatments and Medications
The primary treatment for CNV Type 1 involves anti-vascular endothelial growth factor (
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.